Table 4.
PATIENT# | GRANULOCYTES FROM HEALTHY INDIVIDUALS (C-1–6) | ||||||
---|---|---|---|---|---|---|---|
UNDERLYING DISEASE | STATE | C-1 | C-2 | C-3 | C-4 | ||
1 | RA | Stable | 30.7 | 26.4 | 32.7 | 28.9 | |
AoDILD | 31.3 | 23.3 | 32.7 | 29.4 | |||
2 | RA | Stable | 44.8 | 42.1 | 51.8 | 38.8 | |
AoDILD | 35.5 | 27.1 | 37.8 | 31.9 | |||
3 | RA | Stable | 47.3 | 38.1 | 52.7 | 44.8 | |
AoDILD | 45.7 | 42.5 | 64.8 | 47.8 | |||
HC | 22.8 (2.5) | 19.3 (1.8) | 24.8 (4.5) | 22.7 (0.5) | |||
C-1 | C-2 | C-5 | C-6 | ||||
4 | PM/DM | Stable | 28.9 | 23.0 | 21.1 | 54.7 | |
AoDILD | 28.6 | 25.4 | 25.9 | 59.8 | |||
5 | RA | Stable | 403.0 | 27.3 | 30.5 | 47.8 | |
AoDILD | 28.3 | 24.3 | 28.9 | 58.7 | |||
HC | 22.8 (2.5) | 19.3 (1.8) | 19.2 (0.8) | 45.4 (5.6) |
Notes: The mode fluorescence intensity (MFI) of cells gated for granulocytes in the scattergram is shown. Average values of healthy control group (n = 3) are also shown. Standard deviations are shown in parenthesis.
Abbreviations: GIFT, granulocyte immunofluorescence test; AoDILD, acute-onset diffuse interstitial lung disease; RA, rheumatoid arthritis; PM/DM, polymyositis/dermatomyositis; HC, healthy control.